Lipid-lowering drug therapies: the evidence

被引：0
|
作者：
Packard, C [1 ]
机构：
[1] Royal Infirm, Univ NHS Trust, Dept Pathol Biochem, Glasgow G31 2ER, Lanark, Scotland
来源：
PROCEEDINGS OF THE NUTRITION SOCIETY | 2000年 / 59卷 / 03期
关键词：
lipid-lowering drug therapies; statins; myocardial infarction risk;
D O I：
10.1017/S0029665100000513
中图分类号：
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号：
100403 ;
摘要：
引用
收藏
页码：423 / 424
页数：2
相关论文
共 50 条
  • [1] Lipid-lowering therapies in development
    Wierzbicki, AS
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (11) : 1405 - 1418
  • [2] Lipid-lowering Therapies in Myositis
    Marisa C. Mizus
    Eleni Tiniakou
    Current Rheumatology Reports, 2020, 22
  • [3] Complementary lipid-lowering therapies
    McDermott, JH
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (16) : 1668 - 1671
  • [4] Lipid-lowering therapies in development
    Wierzbicki, A. S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 465 - 465
  • [5] Pharmacogenomics of lipid-lowering therapies
    Hu, Miao
    Tomlinson, Brian
    PHARMACOGENOMICS, 2013, 14 (08) : 981 - 995
  • [6] Lipid-lowering Therapies in Myositis
    Mizus, Marisa C.
    Tiniakou, Eleni
    CURRENT RHEUMATOLOGY REPORTS, 2020, 22 (10)
  • [7] Comparative effects of lipid-lowering therapies
    Davidson, MH
    Toth, PP
    PROGRESS IN CARDIOVASCULAR DISEASES, 2004, 47 (02) : 73 - 104
  • [8] Personalize and Optimize Lipid-Lowering Therapies
    Weingaertner, Oliver
    Luetjohann, Dieter
    Elsaesser, Albrecht
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (03) : 325 - 326
  • [9] Pharmacogenetics of Lipid-lowering Therapies.
    Ordovas J.M.
    Shen H.
    Current Atherosclerosis Reports, 2002, 4 (3) : 183 - 192
  • [10] Lipid-lowering therapies: Better together
    Banach, Maciej
    Penson, Peter E.
    ATHEROSCLEROSIS, 2021, 320 : 86 - 88
12345